Patent ID: 11958903
Assignee: NANJING LEGEND BIOTECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. The anti-LAG-3 construct of claim 18, wherein
(a) the N-terminus of the sdAb specifically recognizing LAG-3 is fused to the C-terminus of the heavy chain of the second antigen binding portion,
(b) the C-terminus of the sdAb specifically recognizing LAG-3 is fused to the N-terminus of the heavy chain of the second antigen binding portion,
(c) the N-terminus of the sdAb specifically recognizing LAG-3 is fused to the C-terminus of the light chain of the second antigen binding portion, or
(d) the C-terminus of the sdAb specifically recognizing LAG-3 is fused to the N-terminus of the light chain of the second antigen binding portion.